FY2026 · ended Jun 30, 2026 · Revenue $142.51M, +9.7% YoY · Filed Sep 28, 2026
Natural Alternatives International, Inc. (NAII) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In fiscal 2026, which ended Jun 30, 2026, it reported revenue of $142.5 million and a net loss of $20.7 million. Free cash flow was -$12.6 million. As of Jun 30, 2026 it held $7.4 million in cash and investments and $40.1 million in total debt.
Revenue
$142.51M
+9.7% vs prior year
Net income
$-20.70M
-52.4% vs prior year
Operating cash flow
$-8.92M
-250.3% vs prior year
Free cash flow
$-12.62M
-644.3% vs prior year
EPS
$-3.43
-50.4% vs prior year
Dividend per share
None
Shares outstanding
22.11M
+258.0% vs prior year
Net cash
$-32.76M
FY 2026
Operating margin
-13.2%
FY 2026
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- NAII (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Carlsbad, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 787253
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Jun 30, 2026 |
FY 2025 Jun 30, 2025 |
FY 2024 Jun 30, 2024 |
FY 2023 Jun 30, 2023 |
FY 2022 Jun 30, 2022 |
|---|---|---|---|---|---|
| Revenue | $142.5M | $129.9M | $113.8M | $154.0M | $171.0M |
| Operating income | -$18.8M | -$8.7M | -$8.5M | $4.7M | $13.7M |
| Net income | -$20.7M | -$13.6M | -$7.2M | $2.5M | $10.7M |
| Diluted EPS | -$3.43 | -$2.28 | -$1.23 | $0.43 | $1.74 |
| Operating cash flow | -$8.9M | $5.9M | -$1.5M | $7.0M | $11.9M |
| Free cash flow | -$12.6M | $2.3M | -$4.5M | -$6.5M | -$14.6M |
| Total assets | $126.4M | $151.9M | $162.3M | $134.2M | $146.0M |
| Total liabilities | $76.5M | $83.5M | $79.7M | $45.4M | $57.5M |
| Stockholders' equity | $50.0M | $68.4M | $82.6M | $88.8M | $88.5M |
| Cash and investments | $7.4M | $12.3M | $12.0M | $13.6M | $21.8M |
| Total debt | $40.1M | $49.2M | $47.8M | $14.5M | $16.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Sep 28, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 19, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change
|
May 1, 2026 | Apr 28, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 20, 2026 | Mar 18, 2026 |
| 10-Q | Quarterly report | Feb 13, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement
|
Dec 17, 2025 | Dec 17, 2025 |
All 777 Natural Alternatives International, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.